The pathogenesis of NIDDM involves a defective expression of the GIP receptor

被引：90
作者：
Holst, JJ
Gromada, J
Nauck, MA
机构：
[1] NOVO NORDISK AS, DEPT ISLET CELL PHYSIOL, COPENHAGEN, DENMARK
[2] RUHR UNIV BOCHUM, KNAPPSCHAFTS KRANKENHAUS, DEPT MED, D-4630 BOCHUM, GERMANY
来源：
DIABETOLOGIA | 1997年 / 40卷 / 08期
关键词：
D O I：
10.1007/s001250050779
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：984 / 986
页数：3
相关论文
共 34 条
[11]   THE INCRETIN NOTION AND ITS RELEVANCE TO DIABETES [J].
HABENER, JF .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1993, 22 (04) :775-794
[12]   GLUCAGON-LIKE PEPTIDE-1 - A NEWLY DISCOVERED GASTROINTESTINAL HORMONE [J].
HOLST, JJ .
GASTROENTEROLOGY, 1994, 107 (06) :1848-1855
[13]   PANCREATIC BETA-CELLS ARE RENDERED GLUCOSE-COMPETENT BY THE INSULINOTROPIC HORMONE GLUCAGON-LIKE PEPTIDE-1(7-37) [J].
HOLZ, GG ;
KUHTREIBER, WM ;
HABENER, JF .
NATURE, 1993, 361 (6410) :362-365
[14]   ALTERED GLUCOSE DEPENDENCE OF GLUCAGON-LIKE PEPTIDE I(7-36)-INDUCED INSULIN-SECRETION FROM THE ZUCKER (FA/FA) RAT PANCREAS [J].
JIA, XY ;
ELLIOTT, R ;
KWOK, YN ;
PEDERSON, RA ;
MCINTOSH, CHS .
DIABETES, 1995, 44 (05) :495-500
[15]   REDUCTION OF THE INCRETIN EFFECT IN RATS BY THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ANTAGONIST EXENDIN(9-39) AMIDE [J].
KOLLIGS, F ;
FEHMANN, HC ;
GOKE, R ;
GOKE, B .
DIABETES, 1995, 44 (01) :16-19
[16]  
Kosaka K, 1996, DIABETIC MED, V13, pS109
[17]   EFFECT OF PORCINE GASTRIC-INHIBITORY POLYPEPTIDE ON BETA-CELL FUNCTION IN TYPE-I AND TYPE-II DIABETES-MELLITUS [J].
KRARUP, T ;
SAURBREY, N ;
MOODY, AJ ;
KUHL, C ;
MADSBAD, S .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1987, 36 (07) :677-682
[18]   Identification of two missense mutations in the GIP receptor gene: A functional study and association analysis with NIDDM - No evidence of association with Japanese NIDDM subjects [J].
Kubota, A ;
Yamada, Y ;
Hayami, T ;
Yasuda, K ;
Someya, Y ;
Ihara, Y ;
Kagimoto, S ;
Watanabe, R ;
Taminato, T ;
Tsuda, K ;
Seino, Y .
DIABETES, 1996, 45 (12) :1701-1705
[19]   THE EFFECT OF GLYBURIDE ON BETA-CELL SENSITIVITY TO GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE [J].
MENEILLY, GS ;
BRYERASH, M ;
ELAHI, D .
DIABETES CARE, 1993, 16 (01) :110-114
[20]   REDUCED INCRETIN EFFECT IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES [J].
NAUCK, M ;
STOCKMANN, F ;
EBERT, R ;
CREUTZFELDT, W .
DIABETOLOGIA, 1986, 29 (01) :46-52
1234